School of Life Science and Technology, Tokyo Institute of Technology, Nagatsuta-cho 4259, Midori-ku, Yokohama, 226-8501, Japan.
SR Life Science Instrumentation Unit, RIKEN/SPring-8 Center, 1-1-1, Kouto, Sayo-cho, Sayo-gun, Hyogo, 679-5148, Japan.
Sci Rep. 2022 Oct 3;12(1):16031. doi: 10.1038/s41598-022-19681-9.
In-cell protein crystallization (ICPC) has been investigated as a technique to support the advancement of structural biology because it does not require protein purification and a complicated crystallization process. However, only a few protein structures have been reported because these crystals formed incidentally in living cells and are insufficient in size and quality for structure analysis. Here, we have developed a cell-free protein crystallization (CFPC) method, which involves direct protein crystallization using cell-free protein synthesis. We have succeeded in crystallization and structure determination of nano-sized polyhedra crystal (PhC) at a high resolution of 1.80 Å. Furthermore, nanocrystals were synthesized at a reaction scale of only 20 μL using the dialysis method, enabling structural analysis at a resolution of 1.95 Å. To further demonstrate the potential of CFPC, we attempted to determine the structure of crystalline inclusion protein A (CipA), whose structure had not yet been determined. We added chemical reagents as a twinning inhibitor to the CFPC solution, which enabled us to determine the structure of CipA at 2.11 Å resolution. This technology greatly expands the high-throughput structure determination method of unstable, low-yield, fusion, and substrate-biding proteins that have been difficult to analyze with conventional methods.
细胞内蛋白质结晶(ICPC)已被研究作为一种支持结构生物学进展的技术,因为它不需要蛋白质纯化和复杂的结晶过程。然而,由于这些晶体是在活细胞中偶然形成的,且大小和质量不足以进行结构分析,因此仅报道了少数几种蛋白质结构。在这里,我们开发了一种无细胞蛋白质结晶(CFPC)方法,该方法涉及使用无细胞蛋白质合成直接进行蛋白质结晶。我们成功地在 1.80Å 的高分辨率下结晶并确定了纳米级多面体晶体(PhC)的结构。此外,通过透析法在仅 20μL 的反应规模上合成了纳米晶体,可实现 1.95Å 的分辨率的结构分析。为了进一步证明 CFPC 的潜力,我们尝试确定尚未确定结构的结晶包含蛋白 A(CipA)的结构。我们向 CFPC 溶液中添加了作为孪晶抑制剂的化学试剂,从而使我们能够以 2.11Å 的分辨率确定 CipA 的结构。这项技术极大地扩展了高通量结构测定方法,使那些用传统方法难以分析的不稳定、低产量、融合和底物结合蛋白的分析成为可能。